EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients

Bingjie Zeng, Anzhi Sheng, Xiao Zhang, Xianzhao Wang, Yunxia Bao, Yiwen Huang, Yiman Huang, Liang Shan, Xin Xu, Yueyang Qin, Yiran Yang, Yiran Deng und 3 weitere

ACS Sensors · 24.10.2025 · 10 (10) · 7388-7402

DOI: 10.1021/acssensors.5c01152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 09.10.2025. Verfasst von Bingjie Zeng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices, B7-H1 Antigen, Neoplastic Cells, Circulating, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Shanghai Chest Hospital, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lab-On-A-Chip DevicesB7-H1 AntigenNeoplastic Cells, CirculatingCarcinoma, Non-Small-Cell LungLung NeoplasmsMicrofluidic Analytical TechniquesHumansMaleFemaleMiddle AgedAgedBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated ProteinsImmune Checkpoint InhibitorsFluorescent Antibody TechniquePrognosisMonitoring, Physiologic

Stichwörter der Autor:innen

CRISPR/Cas12aCTCNSCLCPD-L1immunotherapy

Substanzen

Cas12a proteinBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated ProteinsCD274 protein, humanB7-H1 AntigenImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • Department of Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

ORCID-Profile: Lifang Ma

Förderung

  • Shanghai Chest Hospital
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Zeng, B., Sheng, A., Zhang, X., Wang, X., Bao, Y., Huang, Y., Huang, Y., Shan, L., Xu, X., Qin, Y., Yang, Y., Deng, Y., Tian, L., Wang, J., & Ma, L. (2025). CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients. ACS Sensors, 10(10), 7388-7402. https://doi.org/10.1021/acssensors.5c01152

Vancouver

Zeng B, Sheng A, Zhang X, Wang X, Bao Y, Huang Y, et al. CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients. ACS Sensors. 2025;10(10):7388-7402. doi:10.1021/acssensors.5c01152

BibTeX
@article{Zeng2025,
  author = {Zeng, Bingjie and Sheng, Anzhi and Zhang, Xiao and Wang, Xianzhao and Bao, Yunxia and Huang, Yiwen and Huang, Yiman and Shan, Liang and Xu, Xin and Qin, Yueyang and Yang, Yiran and Deng, Yiran and Tian, Ling and Wang, Jiayi and Ma, Lifang},
  title = {CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients},
  journal = {ACS Sensors},
  year = {2025},
  volume = {10},
  number = {10},
  pages = {7388--7402},
  doi = {10.1021/acssensors.5c01152}
}
Kostenlos starten →